Joseph Walsh, MD
Interventional Cardiology · Boise, IDNPI 1063674505
Payments from drug & device makers
Across 436 payments — averaging $1455.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$579K
- Abbott$40K
- Shockwave Medical, Inc$7K
- Abiomed$4K
- Boston Scientific$4K
- Medtronic$357
- plus $645 from 8 others
What the payments were for
- Consulting fees$44,59439%
- Speaking & faculty fees$37,86533%
- Travel & lodging$18,76316%
- Food & beverage$13,84012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 200 | $578,768 |
| Abbott | 45 | $39,668 |
| Shockwave Medical, Inc | 13 | $7,406 |
| Abiomed | 16 | $4,106 |
| Boston Scientific | 145 | $3,817 |
| Medtronic(2 entities) | 6 | $357 |
| Biotronik Inc. | 2 | $212 |
| Acutus Medical, Inc. | 1 | $145 |
| Opsens Inc. | 1 | $104 |
| Amgen | 3 | $84 |
| BD | 1 | $32 |
| Siemens Medical Solutions USA, Inc. | 1 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Acist Medical Systems, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$29,387
- Edwards SAPIEN 3 Transcatheter Heart Valve$26,060
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$7,250
- Impella$3,822
- CardioMEMS HF System$3,000
- HeartMate 3 Left Ventricular Dev$2,500
- TRICLIP$1,269
- SAPIEN 3 Ultra RESILIA$860
- MitraClip System$301
- Edwards SAPIEN XT Transcatheter Heart Valve$273
- MitraClip$259
- Watchman$246
- PASCAL$150
- WATCHMAN FLX$148
- AVVIGO Guidance System$144
- CoreValve Evolut$141
- 3F$113
- AMPLATZER AMULET$110
- ROTABLATOR$108
- GENERAL - THERAPIES$108
How this compares
$634,766 in reported general payments places this provider in the 95th percentile of 29 interventional cardiology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $14,572 |
| Metoprolol Succinate | 24 | $506 |
| Atorvastatin Calcium | 32 | $216 |
| Carvedilol | 23 | $191 |
| Rosuvastatin Calcium | 12 | $179 |
| ClopidogrelClopidogrel Bisulfate | 21 | $155 |
| Lisinopril | 13 | $55 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Boise
- Jeffrey HeslopBoise$51K
- Kara DenbyBoise$50K
- Kendra CoonseBoise$17K
- Patrick ColemanBoise$11K
- Robert DuerrBoise$11K
- Frederick CostelloBoise$10K
- Alex JohnsonBoise$3K
- David CoyleBoise$3K
- Mark ParentBoise$2K
- Carl KapadiaBoise$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.